Skip to main content
. 2020 Sep 16;27(1):1073274820960467. doi: 10.1177/1073274820960467

Table 2.

Restricted Mean Survival Time (RMST) Between COVID-19 Patients With Lung Cancer and Without Cancer.

Variables Restricted days Lung cancer Non cancer P value
Severe event 10 8.4 (7.5,9.4) 10.0 (10.0,10.0) 0.002
20 14.1 (11.7,16.6) 19.7 (19.3,20.2) <0.001
53 29.5 (21.5,37.4) 46.8 (41.3,52.4) <0.001
ICU 10 9.1 (8.5,9.8) 10.0 (10.0,10.0) 0.013
20 16.9 (14.9,19.0) 20.0 (20.0,20.0) 0.003
53 38.7 (31.5,45.8) 50.3 (46.2,54.5) 0.006
IMV 10 9.9 (9.8,10.1) 10.0 (10.0,10.0) 0.309
20 18.9 (17.9,20.0) 20.0 (20.0,20.0) 0.043
53 46.5 (41.4,51.7) 49.4 (45.5,53.3) 0.386
Death 10 NA NA NA
20 18.9 (17.9,19.9) 20.0 (20.0,20.0) 0.034
53 43.8 (38.2,49.5) 51.6 (49.3,53.9) 0.013

Notes: RMST is a kind of survial time measure method which can be estimated under a restricted period; ICU = intensive care unit; IMV = invasive mechanical ventilation.; N. A = not available.